Diabetes drug semaglutide may boost blood vessel repair cells, small study hints
Disease control
Completed
This completed phase 4 trial tested whether semaglutide (a GLP-1 agonist drug) can improve the health of blood vessel repair cells and fat stem cells in people with type 2 diabetes. Ten participants received either semaglutide or a placebo for 24 weeks. Researchers measured chang…
Phase: PHASE4 • Sponsor: Sabyasachi Sen • Aim: Disease control
Last updated Jun 26, 2026 14:48 UTC